
September 2013 Oncology


Oral antineoplastics have advantages, but patient adherence is a concern.

Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.

Why are computerized drug-drug interaction alerts usually ignored?




Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.

The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis




Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
3
Engineered Stem Cell Therapy Reverses New-Onset T1D in Mice by Reprogramming T Cells
4
CKD Prevalence Unmoved Despite Billions in Virtual Care
5